Cision Vision
Cision Vision is a medtech company specializing in advanced shortwave infrared (SWIR) imaging technologies for pathology and surgery. Their flagship product, Cision InVision, enhances lymph node detection efficiency and accuracy in pathology labs without workflow disruption, using real-time imaging that highlights tissue contrast without dyes or radiation. The company is also developing AI-powered intraoperative imaging solutions to help surgeons identify critical anatomical structures, reducing surgical complications and improving outcomes. Cision Vision has received significant government funding, including a $22.3 million award from ARPA-H's Precision Surgical Interventions program, and collaborates with top cancer care institutions and research teams. Their technology is based on breakthroughs from MIT and is recognized for innovation and design excellence, positioning them as a leader in biomedical imaging for cancer diagnosis and surgical precision.
Cision Vision
Cision Vision is a medtech company specializing in advanced shortwave infrared (SWIR) imaging technologies for pathology and surgery. Their flagship product, Cision InVision, enhances lymph node detection efficiency and accuracy in pathology labs without workflow disruption, using real-time imaging that highlights tissue contrast without dyes or radiation. The company is also developing AI-powered intraoperative imaging solutions to help surgeons identify critical anatomical structures, reducing surgical complications and improving outcomes. Cision Vision has received significant government funding, including a $22.3 million award from ARPA-H's Precision Surgical Interventions program, and collaborates with top cancer care institutions and research teams. Their technology is based on breakthroughs from MIT and is recognized for innovation and design excellence, positioning them as a leader in biomedical imaging for cancer diagnosis and surgical precision.
TL;DR
What they do: Develop shortwave infrared (SWIR) imaging systems for pathology and surgery
Flagship product: InVision — real-time optical device to improve lymph node identification without injections, radiation, or contrast media
Funding highlight: Received an ARPA-H grant (Aug 2024) for $22.3M
Founders / leadership: Jeremy Li, PhD (CEO & Cofounder); Angela Belcher, PhD (Cofounder & Chief Scientific Advisor)
Headquarters: Mountain View, California
Company Overview
Problem Domain
Improving lymph node identification and surgical visualization in pathology and surgical workflows using non-radioactive optical imaging.
Industry
Medical imaging (medtech)
Tech Stack
Funding Track Record
22300000.00
Non-dilutive government grant
Investor Signal
“Receives U.S. government grant funding (ARPA-H lead); National Science Foundation is also associated with the company's funding profile.”